Private Management Group Inc Lowers stake in Chemours Co (CC)

Chemours Co (CC) : Private Management Group Inc reduced its stake in Chemours Co by 5.66% during the most recent quarter end. The investment management company now holds a total of 3,193,770 shares of Chemours Co which is valued at $36,568,667 after selling 191,622 shares in Chemours Co , the firm said in a disclosure report filed with the SEC on Aug 11, 2016.Chemours Co makes up approximately 2.34% of Private Management Group Inc’s portfolio.

Other Hedge Funds, Including , Tiaa Cref Investment Management boosted its stake in CC in the latest quarter, The investment management firm added 275,066 additional shares and now holds a total of 574,383 shares of Chemours Co which is valued at $6,576,685.Cambridge Investment Research Advisors reduced its stake in CC by selling 935 shares or 4.03% in the most recent quarter. The Hedge Fund company now holds 22,256 shares of CC which is valued at $202,530.Anchor Capital Advisors reduced its stake in CC by selling 83,185 shares or 31.02% in the most recent quarter. The Hedge Fund company now holds 184,956 shares of CC which is valued at $1,651,657. Chemours Co makes up approx 0.04% of Anchor Capital Advisors’s portfolio.Nisa Investment Advisors reduced its stake in CC by selling 880 shares or 24.86% in the most recent quarter. The Hedge Fund company now holds 2,660 shares of CC which is valued at $24,871.

Chemours Co opened for trading at $12.48 and hit $12.77 on the upside on Tuesday, eventually ending the session at $12.51, with a gain of 0.48% or 0.06 points. The heightened volatility saw the trading volume jump to 26,55,062 shares. Company has a market cap of $2,271 M.

On the company’s financial health, Chemours Co reported $0.27 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $0.17. The company had revenue of $1383.00 million for the quarter, compared to analysts expectations of $1418.96 million. The company’s revenue was down -8.3 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.10 EPS.

The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.

Leave a Reply

Chemours Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Chemours Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.